Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $638,901 - $1.63 Million
-1,064,836 Reduced 64.52%
585,659 $351,000
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $1.67 Million - $2.59 Million
-1,590,930 Reduced 49.08%
1,650,495 $1.87 Million
Q1 2023

May 15, 2023

BUY
$1.2 - $2.73 $172,680 - $392,847
143,900 Added 4.65%
3,241,425 $4.38 Million
Q4 2022

Feb 14, 2023

SELL
$1.71 - $3.61 $494,754 - $1.04 Million
-289,330 Reduced 8.54%
3,097,525 $5.76 Million
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $204,945 - $930,883
-107,866 Reduced 3.09%
3,386,855 $8.33 Million
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $364,017 - $1.54 Million
170,900 Added 5.14%
3,494,721 $8.53 Million
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $3.29 Million - $8.16 Million
523,578 Added 18.7%
3,323,821 $26.5 Million
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $2.86 Million - $5.57 Million
194,414 Added 7.46%
2,800,243 $42.8 Million
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $7.39 Million - $10.2 Million
303,797 Added 13.2%
2,605,829 $74.1 Million
Q2 2021

Aug 16, 2021

BUY
$26.09 - $40.4 $2.3 Million - $3.56 Million
88,055 Added 3.98%
2,302,032 $77.6 Million
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $12 Million - $20.6 Million
361,910 Added 19.54%
2,213,977 $84.6 Million
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $13.1 Million - $19.2 Million
334,105 Added 22.01%
1,852,067 $77.4 Million
Q3 2020

Nov 16, 2020

BUY
$28.43 - $44.67 $194,319 - $305,319
6,835 Added 0.45%
1,517,962 $65.8 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $4.23 Million - $10.9 Million
361,127 Added 31.4%
1,511,127 $45.8 Million
Q1 2020

May 15, 2020

SELL
$7.64 - $27.5 $382,000 - $1.38 Million
-50,000 Reduced 4.17%
1,150,000 $15.7 Million
Q4 2019

Feb 14, 2020

BUY
$15.02 - $20.57 $1.13 Million - $1.54 Million
75,000 Added 6.67%
1,200,000 $19.4 Million
Q2 2019

Aug 14, 2019

SELL
$17.37 - $26.27 $434,250 - $656,750
-25,000 Reduced 2.17%
1,125,000 $26.4 Million
Q1 2019

May 15, 2019

SELL
$10.65 - $25.75 $2.66 Million - $6.44 Million
-250,000 Reduced 17.86%
1,150,000 $26.9 Million
Q1 2018

May 15, 2018

BUY
$4.69 - $10.05 $440,860 - $944,700
94,000 Added 7.2%
1,400,000 $6.57 Million
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $11.6 Million - $13.6 Million
1,306,000
1,306,000 $12.2 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.